Services / endocrinology weight loss

Tirzepatide Weight Loss Program in Chicago

Tirzepatide is the most powerful FDA-approved weight loss medication available today. As a dual GLP-1/GIP receptor agonist (marketed as Mounjaro for diabetes and Zepbound for weight management), Tirzepatide works through two metabolic pathways for superior results. Clinical trials demonstrated average weight loss of 20-25% of body weight -- making it the most effective medical weight loss treatment ever studied.

Book a visit

What it helps with

Average 20-25% body weight loss in trials

Dual-action mechanism for superior efficacy

Significantly reduces appetite

Once-weekly injection

Improves insulin sensitivity and metabolic health

Greater efficacy than Semaglutide in head-to-head trials

Reduces cardiovascular risk

What happens

01

Comprehensive initial assessment

02

Metabolic panel and body composition analysis

03

Dosing set from your labs with gradual titration

04

Monthly monitoring appointments

05

Nutritional guidance and lifestyle coaching

06

Ongoing management and maintenance planning

Who it is for

Tirzepatide is ideal for adults seeking maximum weight loss results with medical supervision.

Adults with BMI 30+ seeking aggressive weight loss

Those who haven't achieved desired results with Semaglutide

Patients with insulin resistance or type 2 diabetes

Those wanting the most effective FDA-approved option

Questions

Tirzepatide targets two receptors (GLP-1 and GIP) instead of one, which clinical trials show leads to greater average weight loss.